BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 12752889)

  • 21. N-terminal pro Brain Natriuretic Peptide as predictor of outcome in scleroderma renal crisis.
    Chighizola CB; Pregnolato F; Meroni PL; Denton CP; Ong VH
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):122-128. PubMed ID: 27056603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scleroderma renal crisis is still a life-threatening syndrome.
    Stratta P; Besso L; Ferrero S; Canavese C; Hollo S; Ottone S; Sandri L; Thea A; Mazzucco G
    Ren Fail; 1996 Jul; 18(4):567-74. PubMed ID: 8875681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients.
    Teixeira L; Mouthon L; Mahr A; Berezné A; Agard C; Mehrenberger M; Noël LH; Trolliet P; Frances C; Cabane J; Guillevin L;
    Ann Rheum Dis; 2008 Jan; 67(1):110-6. PubMed ID: 17557890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal manifestations of systemic sclerosis--clinical features and outcome assessment.
    Denton CP
    Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v54-6. PubMed ID: 18784147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis.
    Steen VD; Medsger TA
    Arthritis Rheum; 1998 Sep; 41(9):1613-9. PubMed ID: 9751093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal involvement in systemic sclerosis.
    Steen VD
    Clin Dermatol; 1994; 12(2):253-8. PubMed ID: 8076263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studying the Role of C5-Inhibition Therapy in Scleroderma Renal Crisis-Induced Thrombotic Microangiopathy - A Review of Literature.
    Farrukh L; Steen VD; Shapiro L; Mehta S
    Semin Arthritis Rheum; 2023 Dec; 63():152256. PubMed ID: 37689027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Successful use of angiotensin II receptor antagonist (losartan) in a patient with scleroderma renal crisis].
    Hasegawa S; Iesato K; Tsukahara T; Yamamoto S; Kondou Y; Ogawa M; Ueda S
    Nihon Jinzo Gakkai Shi; 2000 Feb; 42(2):60-5. PubMed ID: 10771577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scleroderma renal crisis.
    Hudson M; Ghossein C; Steen V
    Presse Med; 2021 Apr; 50(1):104063. PubMed ID: 33548376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis, management and prevention of scleroderma renal disease.
    Penn H; Denton CP
    Curr Opin Rheumatol; 2008 Nov; 20(6):692-6. PubMed ID: 18946330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Scleroderma renal crisis.
    Steen VD
    Rheum Dis Clin North Am; 1996 Nov; 22(4):861-78. PubMed ID: 8923600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin-converting enzyme inhibitors prior to scleroderma renal crisis in systemic sclerosis: A systematic review and meta-analysis.
    Xiong A; Cao Y; Xiang Q; Song Z; Zhang Y; Zhou S; Qiang Y; Chen H; Hu Z; Cui H; Luo J; Wang Y; Yang Y; Yang M; Shuai S
    J Clin Pharm Ther; 2022 Jun; 47(6):722-731. PubMed ID: 35233779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Scleroderma renal crisis in tropical region: two senegalese cases.
    Cisse MM; Seck SM; Oumar DA; Fall K; Lemrabott AT; Diallo M; Faye M; Faye M; Niang A; Diouf B
    Pan Afr Med J; 2015; 21():46. PubMed ID: 26405482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ACE inhibitors for scleroderma renal crisis.
    Ann Intern Med; 1991 Feb; 114(3):249-50. PubMed ID: 1984753
    [No Abstract]   [Full Text] [Related]  

  • 35. Kidney involvement in systemic sclerosis.
    Steen VD
    Presse Med; 2014 Oct; 43(10 Pt 2):e305-14. PubMed ID: 25174767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Normotensive scleroderma renal crisis in a patient with progressive systemic sclerosis: case report and review of literature.
    Saeed F; Parke A
    Conn Med; 2011 Feb; 75(2):83-7. PubMed ID: 21476377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapy of scleroderma renal crisis: State of the art.
    Zanatta E; Polito P; Favaro M; Larosa M; Marson P; Cozzi F; Doria A
    Autoimmun Rev; 2018 Sep; 17(9):882-889. PubMed ID: 30005860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Renal involvement in patients with systemic sclerosis].
    Bussone G; Noël LH; Mouthon L
    Nephrol Ther; 2011 Jun; 7(3):192-9. PubMed ID: 21524952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Scleroderma renal crisis].
    Teixeira L; Servettaz A; Mehrenberger M; Noël LH; Guillevin L; Mouthon L
    Presse Med; 2006 Dec; 35(12 Pt 2):1966-74. PubMed ID: 17159723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Scleroderma renal crisis: a retrospective multicentre study on 91 patients and 427 controls.
    Guillevin L; Bérezné A; Seror R; Teixeira L; Pourrat J; Mahr A; Hachulla E; Agard C; Cabane J; Vanhille P; Harle JR; Deleveaux I; Mouthon L
    Rheumatology (Oxford); 2012 Mar; 51(3):460-7. PubMed ID: 22087012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.